10646-1-AP
antibody from Proteintech Group
Targeting: HIF1AN
DKFZp762F1811, FIH1, FLJ20615, FLJ22027
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10646-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10646-1-AP, RRID:AB_2232963
- Product name
- HIF1AN antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated HIF1AN antibody (Cat. #10646-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Exclusive Breastfeeding Drives AMPK-Dependent Thermogenic Memory in BAT and Promotes Long-Term Metabolic Benefits in Offspring.
Asb10 accelerates pathological cardiac remodeling by stabilizing HSP70.
LncRNA OIP5-AS1 regulates ferroptosis and mitochondrial dysfunction-mediated apoptosis in spinal cord injury by targeting the miR-128-3p/Nrf2 axis.
Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development.
Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds.
Wu N, Yin A, Yu X, Wang M, Zhang J, Liu K, Hou Y, Cao M, Zhang Y, Zhang X, Gao Y, Guo X, Zhang L, Li Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Feb;13(12):e08956
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Feb;13(12):e08956
Asb10 accelerates pathological cardiac remodeling by stabilizing HSP70.
Lin K, Wei W, Chen S, Gong Y, Wang X, Wang M, Li R, Zhao Y, Xu S, Jin C, Jiang C, Fu G, Li Q
Cell death & disease 2025 May 22;16(1):409
Cell death & disease 2025 May 22;16(1):409
LncRNA OIP5-AS1 regulates ferroptosis and mitochondrial dysfunction-mediated apoptosis in spinal cord injury by targeting the miR-128-3p/Nrf2 axis.
Jiang Z, Zhang W, Zhang J
Heliyon 2024 Sep 30;10(18):e37704
Heliyon 2024 Sep 30;10(18):e37704
Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development.
Lai MC, Zhu QQ, Xu J, Zhang WJ
American journal of cancer research 2021;11(9):4175-4198
American journal of cancer research 2021;11(9):4175-4198
Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds.
Huang J, Yu M, Yin W, Liang B, Li A, Li J, Li X, Zhao S, Liu F
Bioactive materials 2021 Sep;6(9):2841-2853
Bioactive materials 2021 Sep;6(9):2841-2853
No comments: Submit comment
No validations: Submit validation data